Literature DB >> 7140975

Lactosaminated human serum albumin as hepatotropic drug carrier. Rate of uptake by mouse liver.

L Fiume, C Busi, A Mattioli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7140975     DOI： 10.1016/0014-5793(82)80701-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  5 in total

1.  Hepatic disposition characteristics of 111In-labeled lactosaminated bovine serum albumin in rats.

Authors:  K Nishida; Y Eguchi; T Takino; Y Takakura; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

Review 2.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

Review 3.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

4.  A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 5-monophosphate conjugated with lactosaminated albumin.

Authors:  L Fiume; B Bassi; C Busi; A Mattioli; T Wieland
Journal:  Experientia       Date:  1985-10-15

5.  Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.

Authors:  L Fiume; A Mattioli; C Busi; C Accorsi
Journal:  Gut       Date:  1984-12       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.